Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.68 |
| ▸ | VIPR1 | P32241 | 4/20 | 0.65 |
| ▸ | VIPR2 | P41587 | 6/20 | 0.62 |
| ▸ | GLP1R | P43220 | 5/20 | 0.60 |
| ▸ | ECE1 | P42892 | 1/20 | 0.60 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.60 |
| ▸ | CCKBR | P32239 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30063022 | 0.94 | TFPI (0.64) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL30176419 | 0.92 | VIPR1 (0.68) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL30607318 | 0.92 | VIPR1 (0.65) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL30495613 | 0.92 | VIPR1 (0.66) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL31563800 | 0.91 | VIPR1 (0.73) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL30495734 | 0.91 | VIPR1 (0.62) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL30906541 | 0.91 | TFPI (0.61) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL31167348 | 0.91 | TFPI (0.60) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL29489273 | 0.91 | TFPI (0.73) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL31683281 | 0.91 | VIPR1 (0.72) | TFPIVIPR1VIPR2GLP1RECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240003881-A1 | SYSTEM AND METHOD FOR RAPID AND SENSITIVE DETECTION OF ANTI-PATHOGEN ANTIBODIES | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2024-01-04 | — | — | US | disclosed |